University of Notre Dame

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, University of Notre Dame sits in the top decile of US sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count).

13 total trials 7 currently recruiting 5 completed top decile by trial count

University of Notre Dame: 13 sponsored US clinical trials, 7 recruiting.

University of Notre Dame sponsors 13 registered US clinical trials on ClinicalTrials.gov, 7 of them currently recruiting, and 5 completed. The most-studied condition in this pipeline is Behavior, Infant, with 1 trials.

Top-decile sponsor footprint

University of Notre Dame ranks in the top decile of sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

What is open in the University of Notre Dame pipeline

7 recruiting of 13 indexed (54% open); 5 completed (38%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Behavior, Infant (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Notre Dame: open-pipeline peers nationwide

Peers matched on 13 registered trials and 54% open enrollment, not the therapeutic-area sidebar.

University of Notre Dame sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 810121416 0%20%40%60% Total trials Recruiting share University of Notre DameAdaptimmuneAgennixAkili Interactive LabsAlumisChildren's Hospital of Orange CountyAscentage Pharma GroupDisc MedicineHeart Rhythm Clinical and Research Solutions
University of Notre Dame sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Notre Dame sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 13 trials (± recruiting share)

Sponsors near 54% open enrollment (± trial volume)

What to do with this University of Notre Dame page

13 registered trials is a research-attention snapshot, not an endorsement of University of Notre Dame or any single study.

  • 7 of University of Notre Dame's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Behavior, Infant is the condition University of Notre Dame studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Behavior, Infant trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Notre Dame pipeline card: 13 registered trials from official public datasets.Report a data error.